Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression

Adoptive cell therapies (ACTs) using tumor-reactive T cells have shown clinical benefit and potential for cancer treatment. While the majority of the current ACT are focused on using CD8(+) cytotoxic T lymphocytes (CTL), others have shown that the presence of tumor-reactive CD4(+) T helper (Th) cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kunyu, Baird, Margaret, Yang, Jianping, Jackson, Chris, Ronchese, Franca, Young, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007627/
https://www.ncbi.nlm.nih.gov/pubmed/27588200
http://dx.doi.org/10.1038/cti.2016.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007627/
https://www.ncbi.nlm.nih.gov/pubmed/27588200
http://dx.doi.org/10.1038/cti.2016.46

Ejemplares similares